AF-2112
AF-2112 is a flufenamic acid-derived TEAD inhibitor that potently reduces the expression of downstream targets CTGF, Cyr61, Axl, and NF2. This small molecule is a valuable research tool for investigating Hippo signaling pathway biology in both cellular and animal models of cancer and fibrosis.
Product Specifications
CAS Number
2996821-62-4
Field of Research
Stem Cell & Developmental Biology
Smiles
C1=CC=C (C=C1) CCOC2=CC=CC (=C2) NC3=C (C=CC (=C3) F) C (=O) O
Molecular Formula
C21H18FNO3
Molecular Weight
351.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2552704-01 0.01 mg
Recombinant Human Galectin-14/LGALS14 Protein (C-6His)
Sign In for Pricing
View Details MBS2552704-02 0.05 mg
Recombinant Human Galectin-14/LGALS14 Protein (C-6His)
Sign In for Pricing
View Details MBS2552704-03 5x 0.05 mg
Recombinant Human Galectin-14/LGALS14 Protein (C-6His)
Sign In for Pricing
View Details 
![[ (2R,3R,4R,5R,6S) -3,4,6-Triacetyloxy-5-[ (2-azidoacetyl) amino]oxan-2-yl]methyl acetate](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
OR1005048 100 mg
[ (2R,3R,4R,5R,6S) -3,4,6-Triacetyloxy-5-[ (2-azidoacetyl) amino]oxan-2-yl]methyl acetate
Sign In for Pricing
View Details